Twelve Points Wealth Management LLC Sells 8,616 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Twelve Points Wealth Management LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 24.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 26,638 shares of the pharmacy operator’s stock after selling 8,616 shares during the quarter. Twelve Points Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $249,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of WBA. Public Sector Pension Investment Board lifted its holdings in shares of Walgreens Boots Alliance by 76.2% in the second quarter. Public Sector Pension Investment Board now owns 24,726 shares of the pharmacy operator’s stock valued at $299,000 after purchasing an additional 10,696 shares in the last quarter. MBB Public Markets I LLC bought a new stake in Walgreens Boots Alliance in the 2nd quarter valued at approximately $632,000. The Manufacturers Life Insurance Company boosted its position in Walgreens Boots Alliance by 2.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 436,849 shares of the pharmacy operator’s stock worth $5,284,000 after acquiring an additional 8,973 shares during the last quarter. Ascent Group LLC bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $133,000. Finally, Creative Planning grew its stake in shares of Walgreens Boots Alliance by 37.6% during the 2nd quarter. Creative Planning now owns 381,301 shares of the pharmacy operator’s stock worth $4,612,000 after acquiring an additional 104,235 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

WBA has been the subject of several recent research reports. Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. UBS Group lifted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Barclays increased their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Finally, TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $13.27.

Walgreens Boots Alliance Stock Up 3.3 %

NASDAQ:WBA opened at $11.25 on Thursday. The firm’s fifty day moving average price is $9.96 and its two-hundred day moving average price is $9.86. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $23.76. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.66 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.